HomeL9S • FRA
add
Gyre Therapeutics Inc
Previous close
€7.65
Year range
€5.90 - €15.90
Market cap
861.49M USD
Avg Volume
2.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
18 hours ago
S&P 500 needs to fall 40% before buying opportunity of a lifetime: strategist
1.67%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 27.87M | 2.67% |
Operating expense | 26.03M | -16.26% |
Net income | -99.00K | 99.90% |
Net profit margin | -0.36 | 99.90% |
Earnings per share | — | — |
EBITDA | 1.13M | 123.23% |
Effective tax rate | 26.30% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.67M | -20.41% |
Total assets | 125.41M | 7.61% |
Total liabilities | 27.00M | -29.06% |
Total equity | 98.40M | — |
Shares outstanding | 93.61M | — |
Price to book | 10.48 | — |
Return on assets | 1.32% | — |
Return on capital | 1.66% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -99.00K | 99.90% |
Cash from operations | -2.76M | -182.08% |
Cash from investing | -2.00M | -249.66% |
Cash from financing | 964.00K | -61.44% |
Net change in cash | -4.05M | -154.55% |
Free cash flow | -2.91M | — |
About
Founded
1997
Headquarters
Website
Employees
579
